Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Lichtman

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Cancer Investigation|November 27, 2002
The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment studyStuart M Lichtman, Erlinda Etcubanas, Daniel R Budman, et al.
Cancer|August 17, 2016
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapyHarvey Jay Cohen, David Smith, Can-Lan Sun, et al.
Journal of Geriatric Oncology|September 11, 2019
The association between social support and chemotherapy-related toxicity in older patients with cancerArmin Shahrokni, Can-Lan Sun, William P Tew, et al.
Journal of Geriatric Oncology|August 8, 2021
Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)Noam A VanderWalde, Travis Dockter, Daniel V Wakefield, et al.
Journal of Geriatric Oncology|July 22, 2019
Geriatric oncology health services research: Cancer and Aging Research Group infrastructure coreMelisa L Wong, Stuart M Lichtman, Gary R Morrow, et al.
Journal of the American Geriatrics Society|July 22, 2014
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatmentRonald J Maggiore, William Dale, Cary P Gross, et al.
Cancer|February 24, 2012
Use of complementary medications among older adults with cancerRonald J Maggiore, Cary P Gross, Kayo Togawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
Psycho-Oncology|August 8, 2014
The relationship between age, anxiety, and depression in older adults with cancerTalia R Weiss Wiesel, Christian J Nelson, William P Tew, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Cancer Investigation|November 27, 2002
The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment studyStuart M Lichtman, Erlinda Etcubanas, Daniel R Budman, et al.
Cancer|August 17, 2016
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapyHarvey Jay Cohen, David Smith, Can-Lan Sun, et al.
Journal of Geriatric Oncology|September 11, 2019
The association between social support and chemotherapy-related toxicity in older patients with cancerArmin Shahrokni, Can-Lan Sun, William P Tew, et al.
Journal of Geriatric Oncology|August 8, 2021
Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)Noam A VanderWalde, Travis Dockter, Daniel V Wakefield, et al.
Journal of Geriatric Oncology|July 22, 2019
Geriatric oncology health services research: Cancer and Aging Research Group infrastructure coreMelisa L Wong, Stuart M Lichtman, Gary R Morrow, et al.
Journal of the American Geriatrics Society|July 22, 2014
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatmentRonald J Maggiore, William Dale, Cary P Gross, et al.
Cancer|February 24, 2012
Use of complementary medications among older adults with cancerRonald J Maggiore, Cary P Gross, Kayo Togawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
Psycho-Oncology|August 8, 2014
The relationship between age, anxiety, and depression in older adults with cancerTalia R Weiss Wiesel, Christian J Nelson, William P Tew, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
Pageof 13